Quercetin對cisplatin誘發的骨髓抑制之影響

Effects of quercetin on cisplatin-induced myelosuppression

楊容

順鉑 ； 槲皮素 ； 骨髓抑制 ； BALB/c ； 小鼠骨髓細胞株32D ； IL-9 ； GM-CSF ； cisplatin ； quercetin ； myelosuppression ； BALB/c ； IL-9 ； GM-CSF

中山醫學大學營養學系碩士班學位論文

2017年

碩士

葉姝蘭

繁體中文

Cisplatin (CDDP) 是一種無機鉑類化療藥物，廣泛用於治療各種癌症，儘管有顯著的抗腫瘤活性，但也會對正常細胞產生毒性。CDDP引起之副作用有許多，包括骨髓抑制作用，將會造成化療藥物的使用受到限制。Quercetin是一種在植物中含量豐富的類黃酮，研究指出quercetin及其代謝物quercetin-3-O-glucuronide (Q3G) 具有多種的生理活性，亦可能降低化療藥物的副作用。我們先前的研究顯示，quercetin能夠抑制CDDP降低對腫瘤異種移植裸小鼠骨髓細胞數的作用。然而裸小鼠種有免疫缺陷問題，因此本研究中，我們使用具正常免疫系統的BALB/c 小鼠，探討quercetin對CDDP骨髓抑制作用的影響及可能的機制。BALB/c小鼠隨機五組分別為control組、單獨給予CDDP (7.5 mg/kg B.W.，腹腔注射，一週一次)，或CDDP合併quercetin腹腔注射 (10 mg/kg B.W.，一週三次；IQ) 或CDDP合併飼料含0.1% (LQ) 及1% quercetin (HQ)，處理時間為14天。結果顯示，CDDP顯著降低骨髓細胞、白血球、嗜中性球、單核球、紅血球及血小板的數量及血紅素濃度 (p<0.05)，CDDP合併含quercetin的飼料或IQ處理則會增加這些參數，且其效果給予IQ、HQ>LQ；相較CDDP組小鼠，IQ及HQ處理組也明顯有較高血液或/和骨髓造血生長因子interleukin 9 (IL-9)、granulocyte-macrophage colony-stimulating factor (GM-CSF) 與stem cell factor (SCF) 的含量，相反的，IQ、LQ及HQ處理則能降低血液或/和骨髓造血抑制因子tumor necrosis factor alpha (TNF-α) 及transforming growth factor beta 1 (TGF-β1) 及MDA濃度 (p<0.05)；小鼠生長和臟器重量上，IQ、LQ及HQ不但減少CDDP造成的體重、腓腸肌與副睪脂肪的流失及腎臟重量的下降 (p<0.05)，也能降低CDDP誘發的脾臟重量增加 (p<0.05)。 　　為驗證動物實驗的結果，我們利用小鼠骨髓細胞株32D探討quercetin及其代謝物Q3G在濃度0.2 μM下對CDDP (0.3 μM) 抑制32D細胞生長之影響。結果顯示quercetin及Q3G皆顯著 (p<0.05) 抑制CDDP誘發的32D細胞凋亡，同時也伴隨增加CDDP處理細胞的IL-9及GM-CSF的濃度 (p<0.05)，並顯著抑制TNF-α及TGF-β1濃度的升高 (p<0.05)。 　　綜合以上，我們的體內外研究顯示注射及飲食方式給予quercetin及其代謝物Q3G均會降低CDDP誘發的骨髓抑制，其機制與增加造血生長因子及抑制造血抑制因子有關。

Cisplatin (CDDP) is an inorganic platinum-based chemotherapeutic which is being widely administered for treatment of various tumors. Despite the significant anti-tumor activities, cisplatin also shows cytotoxicities to normal cells. These side effects of CDDP are various including bone marrow suppression and may limit the use of CDDP. Quercetin is a flavonoid present abundantly in plants. Studies suggest that quercetin or its metabolites possess various bioactivities and may attenuate the side effects of chemotherapies. Our previous study show that quercetin increase bone marrow cell numbers in tumor-bearing nude mice exposed to CDDP. However, nude mice are immunodeficient. In the current study, we used BALB/c mice (with normal immune system) to investigate the effects of quercetin on myelosuppression induced by CDDP and explored the possible mechanisms. The BALB/c mice were randomly treated with CDDP (7.5 mg/kg B.W., once a week) alone, or in combination with quercetin for 14 days. Quercetin was given by intraperitoneal injection (10 mg/kg B.W., 3 times a week; IQ) or by a quercetin containing diet (0.1% or 1% quercetin diet; LQ and HQ, respectively). The results showed that CDDP significant decreased the numbers of bone marrow cell, total white blood cell, neutrophil, monocyte, red blood cell and platelet as well as the concentration of haemoglobin. CDDP in combination a quercetin containing diet or IQ tended to increased these parameters in the order IQ, HQ>LQ. Furthermore, our results showed that IQ and HQ significantly increased hematopoietic growth factor levels including interleukin 9 (IL-9), granulocyte-macrophage colony-stimulating factor (GM-CSF) and stem cell factor (SCF) levels in the plasma, bone marrow or both in mice exposed to CDDP. In contrast, IQ, LQ and HQ tended to decrease the levels of hematopoietic inhibitory factors, tumor necrosis factor alpha (TNF-αand transforming growth factor beta 1 (TGF-βMDA contents in the plasma and bone marrow. In addition, our results also showed that that IQ, LQ and HQ tended to decrease the loss of body, gastrocnemius muscle, epididymal fat and kidney weight induced by CDDP, while decrease the spleen weight increased by CDDP. To confirm the in vivo findings, we used 32D cell line to study the influences of quercetin and its major metabolite, quercetin-3-O-glucuronide (Q3G), at 0.2 μM on the growth of 32D cells explored CDDP (0.3 μM). We found that both quercetin and Q3G significantly inhibited apoptosis (p<0.05). Accompany the finding, quercetin and Q3G increased the levels of IL-9 or GM-CSF, while decreased the levels of TNF-α and TGF-β1 in 32D cells. In conclusion, our in vivo and in vitro results suggest that quercetin given by intraperitoneal injection or by a quercetin containing diet attenuate CDDP-induced myelosuppression. The mechanisms are associated with the upregulation of hematopoietic growth factors and the downregulation of hematopoietic inhibitory factors.

1. 陳韻竹。Quercetin對化療藥物-cisplatin抗腫瘤效果及副作用的影響。中山醫學大學營養研究所碩士論文。2015。
   連結：
2. 詹淑婷。檞皮酮影響trichostain A 抗癌效果及副作用的研究。中山醫學大學營養研究所博士論文。2015。
   連結：
3. Aldemir M, Okulu E, Kosemehmetoglu K, Ener K, Topal F, Evirgen O, Gurleyik E, Avci A. Evaluation of the protective effect of quercetin against cisplatin-induced renal and testis tissue damage and sperm parameters in rats. Andrologia. 2014, 46:1089-1097.
   連結：
4. Amin K, Janson C, Bystrom J. Role of eosinophil granulocytes in allergic airway inflammation endotypes. Scand J Immunol. 2016, 84:75-85.
   連結：
5. Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food. 2003, 6:391-395.
   連結：
6. Attia SM. The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells. Mutagenesis. 2010, 25:281-288.
   連結：
7. Attyah AM, Ismail SH. Protective Effect of Ginger Extract Against Cisplatin-Induced Hepatotoxicity and Cardiotoxicity in Rats. Iraqi Journal of Pharmaceutical Sciences (ISSN: 1683–3597, ESSN: 2521–3512). 2017, 21:27-33.
   連結：
8. Bai Y, Xia B, Xie W, Zhou Y, Xie J, Li H, Liao D, Lin L, Li C. Phytochemistry and pharmacological activities of the genus Prunella. Food Chem. 2016, 204:483-496.
   連結：
9. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001, 357:539-545.
   連結：
10. Baral S, Pariyar R, Kim J, Lee H-S, Seo J. Quercetin-3-O-glucuronide promotes the proliferation and migration of neural stem cells. Neurobiol Aging. 2017. doi: 10.1016/j.neurobiolaging.2016.12.024
    連結：
11. Bartucci M, Dattilo R, Martinetti D, Todaro M, Zapparelli G, Di Virgilio A, Biffoni M, De Maria R, Zeuner A. Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor. Clin Cancer Res. 2011, 17:6185-6191.
    連結：
12. Bhattacharya P, Thiruppathi M, Elshabrawy HA, Alharshawi K, Kumar P, Prabhakar BS. GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine. 2015, 75:261-271.
    連結：
13. Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol. 1996, 14:636-643.
    連結：
14. Bunel V, Antoine M-H, Nortier J, Duez P, Stévigny C. Nephroprotective effects of ferulic acid, Z-ligustilide and E-ligustilide isolated from Angelica sinensis against cisplatin toxicity in vitro. Toxicol In Vitro. 2015, 29:458-467.
    連結：
15. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 2000, 87:595-600.
    連結：
16. Chen Y, Zou Z, Wu Z, Zhao Z, Luo X, Xie C, Liang Y. TNF-alpha-induced programmed cell death in the pathogenesis of acquired aplastic anemia. Expert Rev Hematol. 2015, 8:515-526.
    連結：
17. Choi EJ, Bae SM, Ahn WS. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res. 2008, 31:1281-1285.
    連結：
18. Choi Y. J., Kang J. S., Park J. H., Lee Y. J., Choi J. S. and Kang Y. H. Polyphenolic flavonoids: structure-activity relationships. Free Radic Biol Med. 2003, 22: 749-60.
    連結：
19. Chow J-M, Shen S-C, Huan SK, Lin H-Y, Chen Y-C. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol. 2005, 69:1839-1851.
    連結：
20. Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol. 2001, 67:93-130.
    連結：
21. Coulie PG, Van den Eynde BJ, Van Der Bruggen P, Boon T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nature Reviews Cancer. 2014, 14:135-146.
    連結：
22. Craig M. Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia. CPT Pharmacometrics Syst Pharmacol. 2017, 6:293-304.
    連結：
23. Cui Y, Wang L, Shi G, Liu L, Pei P, Guo J. Electroacupuncture alleviates cisplatin-induced nausea in rats. Acupunct Med. 2016, 34:120-126.
    連結：
24. Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol. 2012, 143:383-396.
    連結：
25. Daker M, Ahmad M, Khoo AS. Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer Cell Int. 2012, 12:34.
    連結：
26. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014, 740:364-378.
    連結：
27. de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC. Tissue distribution of quercetin in rats and pigs. J Nutr. 2005, 135:1718-1725.
    連結：
28. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & redox signaling. 2013, 18:1818-1892.
    連結：
29. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 2001, 293:829-834.
    連結：
30. Dinarello CA. Proinflammatory cytokines. Chest. 2000, 118:503-508.
    連結：
31. Domitrovic R, Potocnjak I, Crncevic-Orlic Z, Skoda M. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Food Chem Toxicol. 2014, 66:321-328.
    連結：
32. Dranoff G. The Cloning of GM-CSF. The Journal of Immunology. 2017, 198:2519-2521.
    連結：
33. Du Z, Cai H, Ye Z, Tan WS. Optimization of SCF feeding regimen for ex vivo expansion of cord blood hematopoietic stem cells. J Biotechnol. 2012, 164:211-219.
    連結：
34. Endale M, Park S-C, Kim S, Kim S-H, Yang Y, Cho JY, Rhee MH. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 2013, 218:1452-1467.
    連結：
35. Farber MO, Mannix ET. Tissue wasting in patients with chronic obstructive pulmonary disease. Neurol Clin. 2000, 18:245-262.
    連結：
36. Fram RJ. Cisplatin and platinum analogues: recent advances. Curr Opin Oncol. 1992, 4:1073-1079.
    連結：
37. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell. 2009, 16:183-194.
    連結：
38. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol. 1993, 55:1-96.
    連結：
39. Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014, 89:203-212.
    連結：
40. Gong H, Shen P, Jin L, Xing C, Tang F. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice. Cancer Biother Radiopharm. 2005, 20:155-162.
    連結：
41. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011, 186:3283-3288.
    連結：
42. Grover A, Mancini E, Moore S, Mead AJ, Atkinson D, Rasmussen KD, O'Carroll D, Jacobsen SE, Nerlov C. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. J Exp Med. 2014, 211:181-188.
    連結：
43. Guariglia R, Martorelli MC, Lerose R, Telesca D, Milella MR, Musto P. Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients. Biologics. 2016, 10:1-8.
    連結：
44. Haldar S, Dru C, Choudhury D, Mishra R, Fernandez A, Biondi S, Liu Z, Shimada K, Arditi M, Bhowmick NA. Inflammation and pyroptosis mediate muscle expansion in an interleukin-1beta (IL-1beta)-dependent manner. J Biol Chem. 2015, 290:6574-6583.
    連結：
45. Hara T, Ando K, Tsurumi H, Moriwaki H. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur J Haematol. 2004, 73:10-16.
    連結：
46. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983, 32:1141-1148.
    連結：
47. Hitchcock IS, Kaushansky K. Thrombopoietin from beginning to end. Br J Haematol. 2014, 165:259-268.
    連結：
48. Ho GY, Woodward N, Coward JI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol. 2016, 102:37-46.
    連結：
49. Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J. 2013, 27:769-781.
    連結：
50. Hoffmann H, Santos A, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo D, Sabato V, Sanz M. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015, 70:1393-1405.
    連結：
51. Hsieh TC, Wu JM. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res. 2009, 29:4025-4032.
    連結：
52. Ishizawa K, Yoshizumi M, Kawai Y, Terao J, Kihira Y, Ikeda Y, Tomita S, Minakuchi K, Tsuchiya K, Tamaki T. Pharmacology in health food: metabolism of quercetin in vivo and its protective effect against arteriosclerosis. J Pharmacol Sci. 2011, 115:466-470.
    連結：
53. Jia Y, Du H, Yao M, Cui X, Shi Q, Wang Y, Yang Y. Chinese herbal medicine for myelosuppression induced by chemotherapy or radiotherapy: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2015, 2015:690976.
    連結：
54. Kang JW, Kim JH, Song K, Kim SH, Yoon JH, Kim KS. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res. 2010, 24 Suppl 1:S77-82.
    連結：
55. Kawabata K, Mukai R, Ishisaka A. Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct. 2015, 6:1399-1417.
    連結：
56. Keller JR, McNiece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood. 1990, 75:596-602.
    連結：
57. Kim HS, Kim HG, Im HJ, Lee JS, Lee SB, Kim WY, Lee HW, Lee SK, Byun CK, Son CG. Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model. Evid Based Complement Alternat Med. 2017, 2017:9830342.
    連結：
58. Kim J, Cho HJ, Sagong B, Kim SJ, Lee JT, So HS, Lee IK, Kim UK, Lee KY, Choo YS. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines. Biochem Biophys Res Commun. 2014, 449:183-189.
    連結：
59. Knoops L, Renauld J-C. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors. 2004, 22:207-215.
    連結：
60. Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr. 2001, 73:941-948.
    連結：
61. Kouchi Y, Maeda Y, Ohuchida A, Ohsawa M. Immunotoxic effect of low dose cisplatin in mice. J Toxicol Sci. 1996, 21:227-233.
    連結：
62. Koulnis M, Porpiglia E, Hidalgo D, Socolovsky M. Erythropoiesis: from molecular pathways to system properties. Adv Exp Med Biol. 2014, 844:37-58.
    連結：
63. Kumar M, Dahiya V, Kasala ER, Bodduluru LN, Lahkar M. The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats: Molecular and biochemical evidence. Biomed Pharmacother. 2017, 89:1207-1215.
    連結：
64. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013, 2013:162750.
    連結：
65. Larson A, Witman MA, Guo Y, Ives S, Richardson RS, Bruno RS, Jalili T, Symons JD. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res. 2012, 32:557-564.
    連結：
66. Larsson J, Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene. 2005, 24:5676-5692.
    連結：
67. Lazarevic T, Rilak A, Bugarcic ZD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem. 2017. doi: 10.1016/j.ejmech.2017.04.007
    連結：
68. Ledesma E, Martınez I, Cordova Y, Rodrıguez-Sosa M, Monroy A, Mora L, Soto I, Ramos G, Weiss B, Osorio ES. Interleukin-1 beta (IL-1β) induces tumor necrosis factor alpha (TNF-α) expression on mouse myeloid multipotent cell line 32D cl3 and inhibits their proliferation. Cytokine. 2004, 26:66-72.
    連結：
69. Lee BH, Jeong SM, Lee JH, Kim JH, Yoon IS, Lee JH, Choi SH, Lee SM, Chang CG, Kim HC, Han Y, Paik HD, Kim Y, Nah SY. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Mol Cells. 2005, 20:69-73.
    連結：
70. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer. 1999, 79:991-995.
    連結：
71. Lento W, Congdon K, Voermans C, Kritzik M, Reya T. Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb Perspect Biol. 2013, 5.
    連結：
72. Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Pancreatic cancer: diagnosis and treatments. Tumour Biol. 2015, 36:1375-1384.
    連結：
73. Liu M, Tan H, Zhang X, Liu Z, Cheng Y, Wang D, Wang F. Hematopoietic effects and mechanisms of Fufang ejiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice. J Ethnopharmacol. 2014, 152:575-584.
    連結：
74. Londhe P, Guttridge DC. Inflammation induced loss of skeletal muscle. Bone. 2015, 80:131-142.
    連結：
75. Longenbaker S. Anatomy & Physiology: Mader's Understanding Human Anatomy & Physiology, McGraw-Hill. 2010.
    連結：
76. Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. J Clin Oncol. 2004, 22:4302-4311.
    連結：
77. Lyman GH, Lyman CH, Agboola O. Risk models for predicting chemotherapy-induced neutropenia. Oncologist. 2005, 10:427-437.
    連結：
78. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 1998, 426:331-336.
    連結：
79. Marone G, Borriello F, Varricchi G, Genovese A, Granata F. Basophils: historical reflections and perspectives. Chem Immunol Allergy. 2014, 100:172-192.
    連結：
80. Martin SJ, Henry CM. Distinguishing between apoptosis, necrosis, necroptosis and other cell death modalities. Methods. 2013, 61:87-89.
    連結：
81. Marunaka Y. Actions of quercetin, a flavonoid, on ion transporters: its physiological roles. Ann N Y Acad Sci. 2017. doi: 10.1111/nyas.13361
    連結：
82. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012, 95:454-464.
    連結：
83. Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in Neutropenia. J Immunol. 2015, 195:1341-1349.
    連結：
84. Metcalf D. The colony-stimulating factors and cancer. Cancer Immunol Res. 2013, 1:351-356.
    連結：
85. Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani A-M, Johansson MW, Klion AD. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organization Journal. 2016, 9:7.
    連結：
86. Middleton E, Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998, 439:175-182.
    連結：
87. Middleton E, Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000, 52:673-751.
    連結：
88. Mirantes C, Passegue E, Pietras EM. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res. 2014, 329:248-254.
    連結：
89. Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and Its Anti-Allergic Immune Response. Molecules. 2016, 21.
    連結：
90. Moldawer LL, Rogy MA, Lowry SF. The role of cytokines in cancer cachexia. JPEN J Parenter Enteral Nutr. 1992, 16:43S-49S.
    連結：
91. Montoya L. Managing hematologic toxicities in the oncology patient. J Infus Nurs. 2007, 30:168-172.
    連結：
92. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol. 1998, 275:R212-219.
    連結：
93. Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008, 269:315-325.
    連結：
94. Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003, 417:12-17.
    連結：
95. Murphy CC, Harlan LC, Lund JL, Lynch CF, Geiger AM. Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst. 2015, 107.
    連結：
96. Nagai S, Toi M. Interleukin-4 and breast cancer. Breast Cancer. 2000, 7:181-186.
    連結：
97. Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM. An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res. 2008, 68:3835-3843.
    連結：
98. Nasr AY. Protective effect of aged garlic extract against the oxidative stress induced by cisplatin on blood cells parameters and hepatic antioxidant enzymes in rats. Toxicology Reports. 2014, 1:682-691.
    連結：
99. Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy - an update from drug design perspective. Drug Des Devel Ther. 2017, 11:599-616.
    連結：
100. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008, 132:631-644.
     連結：
101. Orsolic N, Car N. Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo. Tumour Biol. 2014, 35:6445-6454.
     連結：
102. Patra K, Bose S, Sarkar S, Rakshit J, Jana S, Mukherjee A, Roy A, Mandal DP, Bhattacharjee S. Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinnamic acid. Chem Biol Interact. 2012, 195:231-239.
     連結：
103. Peres LA, da Cunha AD, Jr. Acute nephrotoxicity of cisplatin: molecular mechanisms. J Bras Nefrol. 2013, 35:332-340.
     連結：
104. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep. 2009, 61:67-75.
     連結：
105. Perez A, Gonzalez-Manzano S, Jimenez R, Perez-Abud R, Haro JM, Osuna A, Santos-Buelga C, Duarte J, Perez-Vizcaino F. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol Res. 2014, 89:11-18.
     連結：
106. Pronk CJ, Veiby OP, Bryder D, Jacobsen SE. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J Exp Med. 2011, 208:1563-1570.
     連結：
107. Qi LW, Wang CZ, Yuan CS. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry. 2011, 72:689-699.
     連結：
108. Ramesh G, Reeves WB. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. Kidney Int. 2004, 65:490-499.
     連結：
109. Ran Y, Wang R, Hasan M, Jia Q, Tang B, Shan S, Deng Y, Qing H. Radioprotective effects of dragon's blood and its extracts on radiation-induced myelosuppressive mice. J Ethnopharmacol. 2014, 154:624-634.
     連結：
110. Rankin SM. The bone marrow: a site of neutrophil clearance. J Leukoc Biol. 2010, 88:241-251.
     連結：
111. Ray-Coquard I, Borg C, Bachelot T, Sebban C, Philip I, Clapisson G, Le Cesne A, Biron P, Chauvin F, Blay JY. Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer. 2003, 88:181-186.
     連結：
112. Rezaee R, Momtazi AA, Monemi A, Sahebkar A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacol Res. 2017, 117:218-227.
     連結：
113. Sahu BD, Kuncha M, Sindhura GJ, Sistla R. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine. 2013, 20:453-460.
     連結：
114. Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal F, Morales AI, Lopez-Novoa JM. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol Dial Transplant. 2011, 26:3484-3495.
     連結：
115. Sarvothaman S, Undi RB, Pasupuleti SR, Gutti U, Gutti RK. Apoptosis: role in myeloid cell development. Blood Res. 2015, 50:73-79.
     連結：
116. Schaafsma MR, Falkenburg JH, Duinkerken N, Van Snick J, Landegent JE, Willemze R, Fibbe WE. Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF. Ann Hematol. 1993, 66:45-49.
     連結：
117. Schilling MB, Parks C, Deeter RG. Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study. Exp Ther Med. 2011, 2:859-866.
     連結：
118. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, Wira CR. Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin Exp Immunol. 2007, 149:155-161.
     連結：
119. Soderberg SS, Karlsson G, Karlsson S. Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling. Ann N Y Acad Sci. 2009, 1176:55-69.
     連結：
120. Sun S, Cai J, Yang Q, Zhao S, Wang Z. The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets. Oncotarget. 2017, 8:16036-16051.
     連結：
121. Sweeney J, Nguyen P, Omann G, Hinshaw D. Ultraviolet irradiation accelerates apoptosis in human polymorphonuclear leukocytes: protection by LPS and GM-CSF. J Leukoc Biol. 1997, 62:517-523.
     連結：
122. Takizawa H, Manz MG. In vivo divisional tracking of hematopoietic stem cells. Ann N Y Acad Sci. 2012, 1266:40-46.
     連結：
123. Terao J. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochem Pharmacol. 2017. doi: 10.1016/j.bcp.2017.03.021
     連結：
124. Thompson GS. Understanding anatomy & physiology, FA Davis. 2015.
     連結：
125. Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: toxicities and management. Drug Saf. 2009, 32:1109-1122.
     連結：
126. Vaidya A, Kale VP. TGF-beta signaling and its role in the regulation of hematopoietic stem cells. Syst Synth Biol. 2015, 9:1-10.
     連結：
127. van de Laar L, Coffer PJ, Woltman AM. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood. 2012, 119:3383-3393.
     連結：
128. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol. 2010, 649:84-91.
     連結：
129. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005, 4:307-320.
     連結：
130. Wang LL, Zhang ZC, Hassan W, Li Y, Liu J, Shang J. Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-beta-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling. Hepatol Res. 2016a, 46:225-238.
     連結：
131. Wang W, Sun C, Mao L, Ma P, Liu F, Yang J, Gao Y. The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review. Trends in Food Science & Technology. 2016b, 56:21-38.
     連結：
132. Wang Y, Meng Q, Qiao H, Jiang H, Sun X. Role of the spleen in cyclophosphamide-induced hematosuppression and extramedullary hematopoiesis in mice. Arch Med Res. 2009, 40:249-255.
     連結：
133. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994, 54:4952-4957.
     連結：
134. Weiss RB, Christian MC. New cisplatin analogues in development. A review. Drugs. 1993, 46:360-377.
     連結：
135. Wiesner C, Nabha SM, Bonfil RD, Dos Santos EB, Yamamoto H, Meng H, Melchior SW, Bittinger F, Thüroff JW, Vessella RL. C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis. Neoplasia. 2008, 10:996-1003.
     連結：
136. Xie X, Yin J, Jia Q, Wang J, Zou C, Brewer KJ, Colombo C, Wang Y, Huang G, Shen J. Quercetin induces apoptosis in the methotrexate-resistant osteosarcoma cell line U2-OS/MTX300 via mitochondrial dysfunction and dephosphorylation of Akt. Oncol Rep. 2011, 26:687-693.
     連結：
137. Xu SF, Yu LM, Fan ZH, Wu Q, Yuan Y, Wei Y, Fang N. Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice. Eur J Pharmacol. 2012, 695:7-12.
     連結：
138. Yamamoto R, Morita Y, Ooehara J, Hamanaka S, Onodera M, Rudolph KL, Ema H, Nakauchi H. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell. 2013, 154:1112-1126.
     連結：
139. Yamanishi Y, Karasuyama H. Basophil-derived IL-4 plays versatile roles in immunity. Semin Immunopathol. 2016, 38:615-622.
     連結：
140. Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, Shimoi K. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking beta(2)-adrenergic signaling. Arch Biochem Biophys. 2014, 557:18-27.
     連結：
141. Yang HH, Hwangbo K, Zheng MS, Cho JH, Son JK, Kim HY, Baek SH, Choi HC, Park SY, Kim JR. Quercetin-3-O-beta-D-glucuronide isolated from Polygonum aviculare inhibits cellular senescence in human primary cells. Arch Pharm Res. 2014, 37:1219-1233.
     連結：
142. Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005, 174:752-757.
     連結：
143. Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010, 31:220-227.
     連結：
144. Yokoyama A, Sakakibara H, Crozier A, Kawai Y, Matsui A, Terao J, Kumazawa S, Shimoi K. Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats. Free Radic Res. 2009, 43:913-921.
     連結：
145. Yousef MI, Hussien HM. Cisplatin-induced renal toxicity via tumor necrosis factor-alpha, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem Toxicol. 2015, 78:17-25.
     連結：
146. Zenitani M, Nojiri T, Kimura T, Hosoda H, Miura K, Hino J, Nakahata K, Uehara S, Miyazato M, Oue T, Okuyama H, Kangawa K. Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice. Cancer Chemother Pharmacol. 2017, 79:363-368.
     連結：
147. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007, 45:27-37.
     連結：
148. Zhao J-l, Zhao J, Jiao H-j. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Appl Biochem Biotechnol. 2014, 172:784-791.
     連結：
149. Zhu XL, Zhu BD. Mechanisms by which Astragalus membranaceus injection regulates hematopoiesis in myelosuppressed mice. Phytother Res. 2007, 21:663-667.
     連結：
150. Zhu YL, Wang LY, Wang JX, Wang C, Wang CL, Zhao DP, Wang ZC, Zhang JJ. Protective effects of paeoniflorin and albiflorin on chemotherapy-induced myelosuppression in mice. Chin J Nat Med. 2016, 14:599-606.
     連結：
151. Zirak MR, Rahimian R, Ghazi-Khansari M, Abbasi A, Razmi A, Mehr SE, Mousavizadeh K, Dehpour AR. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol. 2014, 738:222-229.
     連結：
152. 衛生福利部統計處 (2016) http://www.mohw.gov.tw/cht/DOS/
153. 曾哲明。免疫學，三版，新文京開發。新北。2015。
154. Atalik KE, Keles B, Uyar Y, Dundar MA, Oz M, Esen HH. Vasoprotection by melatonin and quercetin in rats treated with cisplatin. Indian J Exp Biol. 2010, 48:1188-1193.
155. Behling EB, Sendao MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep. 2006, 58:526-532.
156. Cartwright GE, Athens JW, Wintrobe MM. THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN. Blood. 1964, 24:780-803.
157. Duraj J, Zazrivcova K, Bodo J, Sulikova M, Sedlak J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma. 2005, 52:273-279.
158. Henry DH, Brooks BJ, Jr., Case DC, Jr., Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am. 1995, 1:252-260.
159. Khazaei M, Bayat PD, Ghanbari A, Khazaei S, Feizian M, Khodaei A, Alian HA. Protective effects of subchronic caffeine administration on cisplatin induced urogenital toxicity in male mice. Indian J Exp Biol. 2012, 50:638-644.
160. Kindt T, Goldsby R, Osborne B. Kuby immunology. 6th. New York: WH Freeman. xxii; 2007.
161. Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN. Wintrobe's Clinical Hematology, Ninth edition. Malverne, PA, Lea & Febiger. 1993, p. 233.
162. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016, 8:167.
163. Linsalata M, Orlando A, Messa C, Refolo MG, Russo F. Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Res. 2010, 30:3501-3507.
164. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193:265-275.
165. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994, 84:2221-2228.
166. Matous JV, Langley K, Kaushansky K. Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody. Blood. 1996, 88:437-444.
167. OpenStax, Anatomy & Physiology. OpenStax CNX. Feb 26, 2016 http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@8.24.
168. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996, 88:335-340.
169. Renauld J-C, Vink A, Louahed J, Van Snick J. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood. 1995, 85:1300-1305.
170. Xiao M, Wang Y, Tao C, Wang Z, Yang J, Chen Z, Zou Z, Li M, Liu A, Jia C, Huang B, Yan B, Lai P, Ding C, Cai D, Xiao G, Jiang Y, Bai X. Osteoblasts support megakaryopoiesis through production of interleukin-9. Blood. 2017, 129:3196-3209.
171. Yoon C-S, Kim D-C, Ko W-M, Kim K-S, Lee D-S, Kim D-S, Pharm H, Cho H, Pharm H, Seo J. Anti-neuroinflammatory effects of Quercetin-3-O-glucuronide isolated from the leaf of Vitis labruscana on LPS-induced neuroinflammation in BV2 cells. Korean Journal of Pharmacognosy. 2014.